RxDoctor Payments Data

Caitlin Cuffney

Physician Assistant · Buffalo, NYNPI 1235505264

Payments from drug & device makers

$2,425in general payments, 2019–2025

Across 122 payments — averaging $19.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$400
  • AstraZeneca$329
  • Lilly USA, LLC$295
  • Boehringer Ingelheim$195
  • Pfizer$180
  • Amgen$119
  • plus $907 from 20 others

What the payments were for

  • Food & beverage$2,425100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,425 in reported general payments places this provider in the 85th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban191$180,923
TrulicityDulaglutide85$114,510
JardianceEmpagliflozin99$97,265
OzempicSemaglutide55$68,490
MounjaroTirzepatide31$51,362
FarxigaDapagliflozin Propanediol21$27,402
XareltoRivaroxaban23$27,062
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$24,206
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog30$22,913
RybelsusSemaglutide14$21,556
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr38$17,450
Lantus SolostarInsulin Glargine,hum.Rec.Anlog92$15,784
Fluticasone-SalmeterolFluticasone Propion/Salmeterol59$11,839
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$11,648
Atorvastatin Calcium671$11,213

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$180$180,923191 claims
Lilly USA, LLCTrulicity, Mounjaro$295$165,872116 claims
Boehringer IngelheimJardiance$195$97,26599 claims
Novo NordiskOzempic, Rybelsus$400$90,04769 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$102$47,14385 claims
AstraZenecaFarxiga, Symbicort, Pulmicort Flexhaler$329$37,53745 claims
Johnson & JohnsonXarelto$17$27,06223 claims
AbbVieSynthroid$67$4,37865 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →